Allyl 2-(3-(4-butoxybenzoyl)-2-(4-butoxyphenyl)-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate

Catalog No. :
ACOOIJ210
CAS No. :
609796-68-1
Molecular Formula :
C33H36N2O7S
Molecular Weight :
604.72

IUPAC Name:allyl 2-(3-(4-butoxybenzoyl)-2-(4-butoxyphenyl)-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate

Allyl 2-(3-(4-butoxybenzoyl)-2-(4-butoxyphenyl)-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameAllyl 2-(3-(4-butoxybenzoyl)-2-(4-butoxyphenyl)-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate
IUPAC Nameallyl 2-(3-(4-butoxybenzoyl)-2-(4-butoxyphenyl)-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylthiazole-5-carboxylate
MDL No.MFCD04441197
Molecular FormulaC33H36N2O7S
Molecular Weight604.72
SMILESC=CCOC(=O)C1=C(C)N=C(N2C(=O)C(O)=C(C(=O)C3=CC=C(OCCCC)C=C3)C2C2=CC=C(OCCCC)C=C2)S1
InChI KeyHJOCTBZTLYXUMC-UHFFFAOYSA-N
SynonymSALOR-INT L435325-1EA;ALLYL 2-[3-(4-BUTOXYBENZOYL)-2-(4-BUTOXYPHENYL)-4-HYDROXY-5-OXO-2,5-DIHYDRO-1H-PYRROL-1-YL]-4-METHYL-1,3-THIAZOLE-5-CARBOXYLATE
CAS No.609796-68-1

Synthetic Route by SureRoute

1. ACOOIJ210 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOOIJ210 route product structure diagram
    ACOOIJ210609796-68-1
Inquiry

2. ACOOIJ210 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOOIJ210 route product structure diagram
    ACOOIJ210609796-68-1
Inquiry

Comments (0)